Investigating the Effects of Lithium Carbonate on Suicide and Self-harm in Adolescents and Young Adults With Bipolar Disorder in China

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This study aims to use a retrospective cohort approach to explore the impact of lithium carbonate on suicide and self-harm related events among adolescents and young adults with bipolar disorder in China.The primary objective of this study is to investigate the effects of lithium carbonate on suicidal ideation in adolescents and young adults with bipolar disorder in China. Secondary objectives include exploring its effects on preventing suicide attempts, non-suicidal self-injury, and aggressive behaviors in this population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 45
Healthy Volunteers: f
View:

⁃ \-

⁃ 1 For Lithium group

• Aged 12-45 years (adolescents 12-17, young adults 18-45).

• Diagnosed with bipolar disorder using the the Mini-International Neuropsychiatric Interview (M.I.N.I.) (M.I.N.I.; version 5.0) based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria.

• Adolescents diagnosed using the M.I.N.I. Kid version.

• Lithium medication adherence of at least 80% in the first six months over the past year.

• Not in an acute phase of illness.

• Patient or guardian able to participate in assessment interviews.

• Informed consent signed by participants and guardians (for adolescents).

⁃ 2 for Non-lithium group

• Aged 12-45 years (adolescents 12-17, young adults 18-45).

• Diagnosed with bipolar disorder using the Mini-International Neuropsychiatric Interview (M.I.N.I.; version 5.0) based on DSM-IV criteria.

• Adolescents diagnosed using the M.I.N.I. Kid version.

• No lithium use over the past year.

• Not in an acute phase of illness.

• Patient or guardian able to participate in assessment interviews.

• Informed consent signed by participants and guardians (for adolescents).

Locations
Other Locations
China
Mental Health Institute of Peking University
RECRUITING
Beijing
Contact Information
Primary
Xin Yu
yuxin@bjmu.edu.cn
86-10-82801999
Backup
Ni Xu
nixu@bjmu.edu.cn
Time Frame
Start Date: 2024-04-18
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 600
Treatments
Lithium Group
Non-lithium Group
Related Therapeutic Areas
Sponsors
Collaborators: Jiangsu Nhwa Pharmaceutical Co., Ltd.
Leads: Peking University

This content was sourced from clinicaltrials.gov